Literature DB >> 31876542

Diabetic Kidney Disease: Past and Present.

Mohammed Akhtar1,2, Noheir M Taha1,2, Awais Nauman1,2, Imaad B Mujeeb1,2, Ajayeb Dakhilalla M H Al-Nabet1,2.   

Abstract

Diabetes mellitus (DM) afflicting humans has been recognized as a disease for >3000 years. However, very little was known about its etiology and pathogenesis until about a century ago when increasing knowledge about anatomy and physiology of the human body gradually led to our understanding that the hormone insulin produced by the Islets of Langerhans in the pancreas plays a crucial role in the metabolism of glucose and maintaining the blood sugar level within a normal range. DM is caused by inadequate insulin production (type 1) or insulin resistance (type 2). For thousands of years, DM has been considered as a disease of the kidney; however, with the understanding of the pathogenesis of DM, it became clear that diabetic kidney disease (DKD) is a complication and not a cause of DM. DKD is associated with increased matrix expansion that manifests morphologically as a diffuse or nodular expansion of the mesangium and diffuse thickening of the glomerular and tubular basement membranes. Hyperglycemia plays a crucial role in the development of pathologic changes within the kidney. Once established, DKD usually undergoes a slow but relentless progression to end-stage renal disease. However, recent studies have shown that its progression can be slowed or even reversed by strict control of hyperglycemia. Morphologically, DKD may resemble several other glomerular diseases that must be ruled out before a definitive diagnosis. Patients with DM may also develop nondiabetic glomerular or interstitial diseases with or without DKD. The findings in nephrectomy specimens and the differential diagnoses are presented in detail.

Entities:  

Mesh:

Year:  2020        PMID: 31876542     DOI: 10.1097/PAP.0000000000000257

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  16 in total

1.  Circ_0004951 Promotes Pyroptosis of Renal Tubular Cells via the NLRP3 Inflammasome in Diabetic Kidney Disease.

Authors:  Yulin Wang; Li Ding; Ruiqiang Wang; Yanhong Guo; ZiJun Yang; Lu Yu; LiuWei Wang; Yan Liang; Lin Tang
Journal:  Front Med (Lausanne)       Date:  2022-06-06

2.  Screening and Identification of Hub Genes in the Development of Early Diabetic Kidney Disease Based on Weighted Gene Co-Expression Network Analysis.

Authors:  Ran Wei; Jingtao Qiao; Di Cui; Qi Pan; Lixin Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

3.  Effects of Qidantang Granule on early stage of diabetic kidney disease in rats.

Authors:  Tengfei Wu; Xinyu Yang; Yilei Cong; Shisi Xia; Bowen Liu; Ran Zou; Juanhua Zeng; Hua Yang
Journal:  Aging (Albany NY)       Date:  2022-06-13       Impact factor: 5.955

Review 4.  Influence of exercise training on diabetic kidney disease: A brief physiological approach.

Authors:  Liliany Souza de Brito Amaral; Cláudia Silva Souza; Hernando Nascimento Lima; Telma de Jesus Soares
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-02

5.  Baicalin serves a protective role in diabetic nephropathy through preventing high glucose-induced podocyte apoptosis.

Authors:  Jindong Li; Ya Ling; Shengnan Yin; Shufang Yang; Min Kong; Zhiqin Li
Journal:  Exp Ther Med       Date:  2020-04-29       Impact factor: 2.447

Review 6.  Incretins in the Therapy of Diabetic Kidney Disease.

Authors:  Agnieszka Przezak; Weronika Bielka; Andrzej Pawlik
Journal:  Int J Mol Sci       Date:  2021-11-15       Impact factor: 5.923

7.  Sp1-Induced lncRNA Rmrp Promotes Mesangial Cell Proliferation and Fibrosis in Diabetic Nephropathy by Modulating the miR-1a-3p/JunD Pathway.

Authors:  Hansen Yang; Jia Wang; Zheng Zhang; Rui Peng; Dan Lv; Handeng Liu; Yan Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-27       Impact factor: 5.555

Review 8.  Role of Insulin in Health and Disease: An Update.

Authors:  Md Saidur Rahman; Khandkar Shaharina Hossain; Sharnali Das; Sushmita Kundu; Elikanah Olusayo Adegoke; Md Ataur Rahman; Md Abdul Hannan; Md Jamal Uddin; Myung-Geol Pang
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

Review 9.  Abnormal Iron and Lipid Metabolism Mediated Ferroptosis in Kidney Diseases and Its Therapeutic Potential.

Authors:  Xiaoqin Zhang; Xiaogang Li
Journal:  Metabolites       Date:  2022-01-10

Review 10.  Current Challenges and Future Perspectives of Renal Tubular Dysfunction in Diabetic Kidney Disease.

Authors:  Suyan Duan; Fang Lu; Dandan Song; Chengning Zhang; Bo Zhang; Changying Xing; Yanggang Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-10       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.